Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Gliosarcoma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Temozolomide 48 Bevacizumab 29 Carmustine 17 Erlotinib Hydrochloride 16 Radiotherapy 14 Irinotecan 14 Surgical Procedures, Operative 10 Sirolimus 10 Imatinib Mesylate 10 Carboplatin 10 Sorafenib 9 O(6)-benzylguanine 9 Filgrastim 9 Etoposide 8 temsirolimus 7 sargramostim 7 Radiosurgery 7 Radiation 7 Procarbazine 7 Magnetic Resonance Spectroscopy 7 Cyclophosphamide 7 aldesleukin 6 Topotecan 6 Thalidomide 6 Vorinostat 5 Thiotepa 5 Peripheral Blood Stem Cell Transplantation 5 Hydroxyurea 5 Gefitinib 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Basiliximab × Sarcoma × Clear all

NCT00626483 2021-03-09

REGULATe

Duke University

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡